Clinical protocols should be developed with a qualified healthcare provider

certificate of analysis available on request Research Applications Suitable Laboratory Uses for FOXO4-DRI FOXO4-p53 protein-protein interaction disruption assays CO-IP, competitive binding, and proximity ligation studies Selective senescent cell apoptosis induction SA--gal, p16, p21, p53 marker-confirmed senescent populations p53 TAD2 binding, phospho-p53 (Ser15) nuclear exclusion, and mitochondrial translocation pathway studies BAX/BCL-2/Caspase-3 intrinsic apoptosis cascade investigations in senescent cell models SASP characterisation and suppression IL-6, IL-8, MMP, VEGF, CXCL2/3 secretome studies Tissue-specific senescence models fibroblasts, endothelial cells, Leydig cells, chondrocytes, keloid fibroblasts Vascular ageing pathway research endothelial senescence, aortic function, and ROS pathway studies Senescent cancer cell biology and drug resistance pathway research Comparative senolytic research FOXO4-DRI vs
Bradshaw, M
The interest of this product is clearly its high concentration of copper peptides: 1% pure copper peptides including 1% in free form (GHK peptide/Tripeptide-1 and Copper Tripeptide-1/GHK-Cu) Please dont ask me to explain what that means, Im not able to, Im far from being a chemistry expert (but in short, it means it contains a lot of copper peptides!)
Articles like yours have been a big part of my learning curve